Hemostats Market Forecasting from 2025 - 2031

Posted 2026-02-06 17:45:47

15K

Market Overview

The Hemostats Market includes agents and devices helping in controlling bleeding during surgical procedures or traumatic injuries. These products enhance hemostasis by either accelerating blood clot formation or sealing tissues or creating physical barriers at the bleeding location. The hemostats market includes mechanical and active and flowable and combination products which serve general surgery and cardiovascular surgery and orthopedic procedures and trauma care. The market expands because of worldwide surgical volume increases and rising surgical operation blood loss management requirements. The industry evolves because of new biodegradable hemostatic agents and surgeons choosing minimally invasive procedures with safety features.

Key Players

Baxter International Inc, Ethicon Johnson Johnson, B Braun Melsungen AG, Medtronic plc, Stryker Corporation, Becton Dickinson and Company, Integra LifeSciences Corporation, Terumo Corporation, Teleflex Incorporated, Pfizer Inc, Smith Nephew plc, Zimmer Biomet Holdings Inc, CryoLife Inc, Biomup, Anika Therapeutics Inc, Cohera Medical Inc, Hemostasis LLC, Equimedical, Arch Therapeutics Inc, Haemostatix Limited

Sample link - https://www.trendbridgeinsights.com/industry-report/hemostats-market

Market segmentation:

Product Type

· Thrombin-based Hemostats

· Gelatin-based Hemostats

· Oxidized Regenerated Cellulose-based Hemostats

· Combination Hemostats

· Fibrin Sealants

Application

· Surgery

· Trauma

· Wound Closure

· Cardiovascular Procedures

· Obstetrics

End User

· Hospitals

· Ambulatory Surgical Centers

· Specialty Clinics

· Nursing Homes

· Others

Sales Channel

· Direct Sales

· Distributor Sales

· Online Sales

· Retail Pharmacies

· Others

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

North America leads the hemostats market due to high surgical volumes, advanced healthcare infrastructure, and early adoption of innovative surgical tools. Europe follows with stable demand from aging populations and elective surgeries. Asia-Pacific grows fastest, driven by expanding healthcare access, rising surgical procedures, and medical tourism, while Latin America and MEA show steady growth.

Recent development :

In April 2025, Baxter launched a room temperature version of Hemopatch Sealing Hemostat in Europe which provides quick and easy use at room temperature and maintains its shelf life for three years for open and minimally invasive surgical procedures.

FAQ:

1 . What is the Forecasted market size & CAGR of the Hemostats Market ?

The Hemostats Market reached USD 3.5 billion in 2024, as analysts predict it will reach USD 6.8 billion by 2031 at a compound annual growth rate (CAGR) of 9–10%.

2. Who are the leading manufacturers and suppliers in the Hemostats Market ?

Baxter International Inc, Ethicon Johnson Johnson, B Braun Melsungen AG, Medtronic plc, Stryker Corporation, Becton Dickinson and Company, Integra LifeSciences Corporation, Terumo Corporation

3. What are the upcoming trends of Hemostats Market in the globe?

Bioactive & Combination Hemostats: The market shows an increasing trend toward hemostatic agents that perform mechanical, chemical and biological functions. Surgical procedures benefit from products that unite thrombin or fibrinogen with collagen or gelatin matrices because they enhance both clot formation and tissue adherence leading to superior control in complex surgical procedures.

4. Which is the largest regional market for Hemostats Market ?

The hemostats market is led by North America because the United States has high surgical volumes and advanced healthcare infrastructure and favorable reimbursement policies.

About US: